INOVIO Pharmaceuticals
NEWS ALERT

INOVIO to Begin Rolling Submission of BLA for INO-3107 for the Treatment of RRP in Adults

Press Releases

INOVIO to Report Second Quarter Financial Results on August 12, 2026

Posted on August 19, 2026

INOVIO Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Posted on August 19, 2026

INOVIO to Report First Quarter Financial Results on May 13, 2026

Posted on August 19, 2026

INOVIO to Participate in Upcoming Scientific Conferences

Posted on August 19, 2026

INOVIO Reports First Quarter 2026 Financial Results and Recent Business Highlights

Posted on August 19, 2026

Positive Topline Results from a Phase 3 Trial for VGX-3100 in Cervical Dysplasia Patients Announced by ApolloBio, INOVIO’s Partner in China

Posted on August 19, 2026

INOVIO to Participate in Upcoming Scientific and Investor Conferences

Posted on August 19, 2026

INOVIO Announces Proposed Public Offering

Posted on August 19, 2026

INOVIO Announces Pricing of $20.0 Million Public Offering

Posted on August 19, 2026

INOVIO Announces Pricing of $17.5 Million Public Offering

Posted on August 19, 2026

© Copyright 2026 INOVIO Pharmaceuticals. All rights reserved.